LYN
LYN is a non-receptor tyrosine-protein kinase of the Src family that relays signals from cell surface receptors and helps regulate innate and adaptive immune responses. It is also known as JTK8, and formerly as v-yes-1 Yamaguchi sarcoma viral related oncogene homolog. Browse Assay Genie's current range of LYN research reagents below, or read on for the biology behind the target.
LYN transmits signals from cell surface receptors and takes part in the regulation of innate and adaptive immunity, haematopoiesis, responses to growth factors and cytokines, integrin signalling, and responses to DNA damage and genotoxic agents. It functions primarily as a negative regulator but can also act as an activator, depending on context. In B cells it is required to initiate the response and also for its down-regulation and termination, and it contributes to B-cell differentiation, proliferation, survival, apoptosis and immune self-tolerance.
A major inhibitory mechanism is phosphorylation of immunoreceptor tyrosine-based inhibitory motifs (ITIMs). These then act as binding sites for phosphatases such as PTPN6/SHP-1, PTPN11/SHP-2 and INPP5D/SHIP-1, which dampen signalling by dephosphorylating kinases and their substrates. LYN acts downstream of the B-cell receptor, CD79A, CD79B, CD5, CD19, CD22, FCER1, FCGR2, FCGR1A, TLR2 and TLR4, and downstream of EPOR, KIT, MPL, CXCR4 and the receptors for IL3, IL5 and CSF2. Its substrates include BTK, CBL, CD19, CD79A, CD79B, DOK1, SYK and TEC. It also regulates phosphatidylinositol 3-kinase activity, AKT1 activation, MAP kinase cascades and STAT5A/STAT5B activation, and its kinase activity facilitates TLR4-TLR6 heterodimerisation and the macrophage response to bacterial lipopolysaccharide.
The LYN gene encodes a member of the Tyr protein kinase family, SRC subfamily, within the protein kinase superfamily. HGNC places it in the SH2 domain containing and SH3 domain containing groups. NCBI Gene notes that it may be involved in regulating mast cell degranulation and erythroid differentiation, and that alternatively spliced transcript variants encode different isoforms. The protein is found at the cell membrane, in the cytoplasm including the perinuclear region, in the nucleus and at the Golgi apparatus. Mouse and rat orthologs are both named Lyn.
LYN both initiates and terminates B-cell responses and supports immune self-tolerance, making it central to studies of B-cell receptor signalling.
LYN acts downstream of TLR2 and TLR4 and shapes the macrophage cytokine response to bacterial lipopolysaccharide.
LYN mediates signals from EPOR, KIT, MPL, CXCR4 and IL3, IL5 and CSF2 receptors in progenitors and mature myeloid cells.
Through ITIM phosphorylation and recruitment of SHP-1, SHP-2 and SHIP-1, LYN is a model for balancing activating and inhibitory signals.
LYN is a non-receptor tyrosine kinase that transmits signals from immune receptors, cytokine and growth factor receptors and integrins. It mainly acts as a negative regulator, for example by phosphorylating ITIMs that recruit phosphatases, but it can also activate pathways depending on context.
LYN is also known as JTK8, and its previous HGNC name was v-yes-1 Yamaguchi sarcoma viral related oncogene homolog. The full approved name is LYN proto-oncogene, Src family tyrosine kinase. NCBI Gene reports that alternatively spliced transcript variants encode different isoforms.
Yes. Mouse and rat both have a Lyn ortholog, so the kinase can be studied in rodent models of immune and haematopoietic signalling. Check the datasheet of any product for its validated reactivity.
Other Src family signalling kinases, immune receptors, phosphatases and substrates that work alongside LYN.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P07948; product specifications from Assay Genie datasheets.